BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 12, 2018
View Archived Issues
Psoriasis and plaques
Read More
Small-molecule inhibitor of urokinase plasminogen activator ameliorates multiple sclerosis in mice
Read More
Small-molecule hepcidin production inhibitor developed for treatment of anemia of chronic disease
Read More
Novel RORgammat inhibitors developed by Shionogi for treating Th17-mediated autoimmune diseases
Read More
Interaction partner identification finds Myc's friends, and vulnerabilities
Read More
Seal Rock Therapeutics announces preclinical data for SRT-015 in NASH
Read More
CRISPR Therapeutics and MaxCyte expand clinical and commercial license agreement into oncology
Read More
Shanghai Jiongshuo Pharmaceutical Technology identifies CDK9/cyclin T1 inhibitors
Read More
FDA grants accelerated approval to Keytruda for HCC previously treated with sorafenib
Read More
GlaxoSmithKline patents PI3K inhibitors
Read More
FDA approves Yupelri for maintenance treatment of COPD
Read More
FDA issues EUA for DPP Ebola Antigen System
Read More
Harpoon Therapeutics to use series C proceeds to support cancer immunotherapy pipeline
Read More
New phase III trial investigates emixustat in macular atrophy secondary to Stargardt disease
Read More
Retrotope begins phase II/III study of RT-001 in infantile neuroaxonal dystrophy
Read More
Phase I data on BBT-401 pave way for phase II ulcerative colitis study
Read More
Adjunctive LHW-090 safely lowers blood pressure in patients with resistant hypertension
Read More
Purinergic receptor mutations cause congenital neurogenic bladder
Read More
Mutations in DKGE cause C3 glomerulopathy
Read More
Combination of IDLV-SIV-Gag and IDLV-PGT121 results in prolonged virus control in vivo
Read More
SCaV11 immunogen selectively elicits CD8+ T cells but not CD4+ T cells targeting viral antigens
Read More
Genetic determinants of cortical thickness in Alzheimer's disease revealed
Read More
Activation of the cellular stress response protects cells from neurotoxicity in Parkinson's disease
Read More
Gilead presents first-in-human data for GS-9688 at The Liver Meeting
Read More
PACAP/PAC1 signaling protects retinal neurons from death in mice with multiple sclerosis
Read More
Sierra completes IND filing for phase I/II trial of SRA-141 in colorectal cancer
Read More